Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoquinone Ointment for Psoriasis Vulgaris
NCT06508372Not yet recruiting
- Sponsor
- Assiut University
- Start
- Aug 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in Psoriasis vulgaris (PV) comparing Topical Thymoquinone Ointment with Topical Placebo Ointment (2 arms). Primary endpoint: Psoriasis severity score (TES) at 3 months. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
thymoquinone
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT06508372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06508372.